ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
95 672,43
-1,58%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. HCW Biologics Inc (HCWB) Cours

HCW Biologics Inc

HCW Biologics Inc (HCWB)

NASDAQ
0,449
0,036
(8,72%)
Fermé 22 Décembre 10:00PM
Retardé de 15 minutes
0,44
-0,009
(-2,00%)
Après les heures de négociation: 1:54AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,44
Prix Achat
0,30
Prix Vente
0,45
Volume échangé
367 080
0,39 Fourchette du Jour 0,45
0,2721 Plage de 52 semaines 2,52
Cap du marché
16,642M
Clôture Veille
0,413
Ouverture
0,4006
Dernière Transaction
125
@
0.44
(formt)
Dernière heure de transaction
Volume financier
US$ 157 870
VWAP
0,43007
Volume moyen (3 m)
9 827 006
Actions en circulation
37 823 394
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,67
Bénéfice par action (BPA)
-0,66
Chiffre d'affairess
2,84M
Bénéfice net
-24,99M

À propos de HCW Biologics Inc

HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a signi... HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.hcwbiologics.com
Siège social
Wilmington, Delaware, USA
Fondé
-
HCW Biologics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker HCWB. Le dernier cours de clôture d'HCW Biologics était de US$0,41. Au cours de la dernière année, les actions de HCW Biologics ont été négociées dans une fourchette de prix de US$ 0,2721 à US$ 2,52.

HCW Biologics compte actuellement 37 823 394 actions en circulation. La capitalisation boursière d'HCW Biologics est de US$15,62 million. HCW Biologics a un ratio cours/bénéfice (ratio PE) de -0.67.

HCWB Dernières nouvelles

Plus de nouvelles

Form D - Notice of Exempt Offering of Securities

05 Décembre 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

22 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

22 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

20 Novembre 2024
Edgar (US Regulatory)

Form 424B2 - Prospectus [Rule 424(b)(2)]

20 Novembre 2024
Edgar (US Regulatory)

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

MIRAMAR, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and...

19 Novembre 2024
GlobeNewswire Inc.

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate

HCW Biologics entered into License, Research and Co-Development Agreement with WY Biotech for one of its new proprietary preclinical molecules HCW Biologics to receive upfront payment of $7...

18 Novembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

18 Novembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

14 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.06617.64705882350.3740.440.324185790.3813077CS
4-0.26-37.14285714290.70.79460.327309570.55279478CS
12-0.069586-13.65539869620.5095862.520.272198270061.20038341CS
26-0.56-5612.520.272146187501.19889456CS
52-0.83-65.35433070871.272.520.272123533361.19933786CS
156-2-81.96721311482.443.320.27218017231.22144525CS
260-7.06-94.13333333337.57.510.27219322912.05462849CS

HCWB - Frequently Asked Questions (FAQ)

What is the current HCW Biologics share price?
The current share price of HCW Biologics is US$ 0,44
How many HCW Biologics shares are in issue?
HCW Biologics has 37 823 394 shares in issue
What is the market cap of HCW Biologics?
The market capitalisation of HCW Biologics is USD 15,62M
What is the 1 year trading range for HCW Biologics share price?
HCW Biologics has traded in the range of US$ 0,2721 to US$ 2,52 during the past year
What is the PE ratio of HCW Biologics?
The price to earnings ratio of HCW Biologics is -0,67
What is the cash to sales ratio of HCW Biologics?
The cash to sales ratio of HCW Biologics is 5,86
What is the reporting currency for HCW Biologics?
HCW Biologics reports financial results in USD
What is the latest annual turnover for HCW Biologics?
The latest annual turnover of HCW Biologics is USD 2,84M
What is the latest annual profit for HCW Biologics?
The latest annual profit of HCW Biologics is USD -24,99M
What is the registered address of HCW Biologics?
The registered address for HCW Biologics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the HCW Biologics website address?
The website address for HCW Biologics is www.hcwbiologics.com
Which industry sector does HCW Biologics operate in?
HCW Biologics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,5M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,63M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,84M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
8,58M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
5,96M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
HCWB
HCW Biologics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés